Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS).
暂无分享,去创建一个
V. Lorenzoni | A. Scholte | J. Knuuti | D. Neglia | R. Buechel | S. Rocchiccioli | O. Parodi | R. Ragusa | C. Caselli | J. Smit | M. Schütte | G. Pelosi | M. El Mahdiui | A. Teresińska | M. Pizzi | R. Poddighe | A. Roque | N. Di Giorgi | M. N. Pizzi | Mohammed El Mahdiui